What are the main causes of increased LDL cholesterol and triglycerides?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Main Causes of Increased LDL Cholesterol and Triglycerides

The primary causes of elevated LDL cholesterol and triglycerides fall into three major categories: dietary factors (saturated fat, cholesterol, alcohol, refined carbohydrates), secondary medical conditions (obesity, diabetes, hypothyroidism, kidney disease), and medications (thiazide diuretics, beta-blockers, oral estrogens, corticosteroids, retinoids, protease inhibitors). 1

Dietary and Lifestyle Causes

For LDL cholesterol elevation:

  • Saturated fat intake is the principal dietary determinant of LDL cholesterol levels 2
  • Dietary cholesterol increases LDL, though to a lesser extent than saturated fat 3
  • Trans-fatty acids from partially hydrogenated oils raise LDL and lower HDL 3

For triglyceride elevation:

  • Alcohol is one of the most common causes—it increases hepatic fatty acid synthesis and decreases oxidation, stimulating VLDL secretion in a dose-dependent manner 1
  • Excess body weight and central obesity are critical factors 1, 2
  • Refined carbohydrates and sugar intake, particularly in insulin-resistant individuals 2
  • Reduced physical activity 2

Secondary Medical Conditions

Endocrine disorders:

  • Hypothyroidism is the most common secondary cause after dietary factors 4
  • Diabetes mellitus (both type 1 and 2)—untreated diabetes with insulin deficiency commonly causes hypertriglyceridemia; type 2 diabetes typically shows mild hypertriglyceridemia related to central obesity and insulin resistance 1, 5
  • Acromegaly—causes hypertriglyceridemia through increased insulin resistance and decreased hepatic lipase and LPL activity 1
  • Pregnancy—triglycerides increase progressively, with third trimester levels 200% or more above baseline due to estrogen-induced hepatic triglyceride-rich lipoprotein secretion 1

Renal disease:

  • Nephrotic syndrome causes increased hepatic production of apoB-containing lipoproteins including VLDL 1
  • Renal failure causes hypertriglyceridemia through decreased clearance of triglyceride-rich lipoproteins 1

Other conditions:

  • Lipodystrophy (HIV-associated or autoimmune)—acquired forms show hypertriglyceridemia with hepatic steatosis 1
  • Autoimmune diseases (systemic lupus erythematosus, multiple myeloma)—involve autoantibodies to LPL, apoC-II, or heparin 1
  • Infections, inflammation, and sepsis—increase VLDL production 1
  • Severe stress—may relate to catecholamine-induced adipose tissue lipolysis and reduced LPL activity 1

Medications That Raise Lipids

Drugs that increase triglycerides:

  • Thiazide and furosemide diuretics 1
  • Beta-adrenergic blockers (atenolol, metoprolol, propranolol more than carvedilol)—effects most relevant in patients with underlying genetic hypertriglyceridemia 1
  • Oral estrogens—increase hepatic VLDL secretion; can provoke severe pancreatitis in patients with familial hypertriglyceridemia or LPL deficiency 1
  • Retinoids (isotretinoin, bexarotene)—increase hepatic VLDL and apoC-III production 1
  • Protease inhibitors (ritonavir, lopinavir) for HIV 1
  • Immunosuppressants (sirolimus, cyclosporine, tacrolimus) 1
  • Second-generation antipsychotics (clozapine, olanzapine, risperidone, quetiapine)—particularly those associated with weight gain and metabolic syndrome 1
  • Glucocorticoids 1
  • Bile acid sequestrants can worsen hypertriglyceridemia, especially in patients with baseline triglycerides >200 mg/dL 1

Clinical Approach

The Endocrine Society recommends that patients with primary hypertriglyceridemia be assessed for cardiovascular risk factors including central obesity, hypertension, abnormalities of glucose metabolism, and liver dysfunction 1. This systematic evaluation is essential because:

  • Multiple secondary causes often coexist in the same patient
  • Identifying reversible causes is critical before initiating lipid-lowering therapy 6, 7
  • In patients with underlying genetic lipid disorders, secondary causes can trigger severe complications—for example, oral estrogens or alcohol superimposed on familial hypertriglyceridemia can saturate removal mechanisms and cause life-threatening pancreatitis 4

Common pitfall: Failing to recognize that elevated triglycerides with elevated cholesterol can represent three distinct patterns: (1) elevated VLDL and/or LDL (as in familial combined hyperlipidemia), (2) elevated VLDL and chylomicron remnants (familial dysbetalipoproteinemia), or (3) severe hypertriglyceridemia with increased VLDL and chylomicron cholesterol 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.